Nicholas Bandarenko III
Associate Professor of Pathology
Blood banking, transfusion medicine, apheresis(donor, therapeutic, cellular therapy), blood components, blood utilization
Current Appointments & Affiliations
- Associate Professor of Pathology, Pathology, Clinical Science Departments 2008
Contact Information
- Duke Box 3712, Durham, NC 27708
- Rm. 1720 Duke North, Box 3712, Med. Ctr., Durham, NC 27710
-
nick.b@duke.edu
(919) 681-4666
- Background
-
Education, Training, & Certifications
- Fellow-Blood Bank, Pathology, University of North Carolina - Chapel Hill 1995 - 1996
- Resident- Anatomic & Clinical Pathology, Pathology, Duke University 1990 - 1995
- M.D., Wake Forest University 1990
-
Previous Appointments & Affiliations
- Instructor, Temporary in the Department of Pathology, Pathology, Clinical Science Departments 2008
-
Academic Positions Outside Duke
- Associate Professor, University of North Carolina, Chapel Hill. 1996 - 2008
- Recognition
-
Awards & Honors
- Research
-
Selected Grants
- Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE) awarded by University of Maryland, Baltimore 2022 - 2023
- Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE) awarded by University of Pittsburgh 2020 - 2022
- Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications awarded by Mayo Clinic 2014 - 2020
- A Randomized Double-Blind, Phase 3 Study Comparing the Efficacy and Safety of High-Titer versus Low-Titer Anti-Influenza Immune Plasma for the Treatment of Severe Influenza A; IRC-005 awarded by Social & Scientific Systems, Inc. 2015 - 2019
- HB Manual QC Field Trial awarded by Hemo Bioscience Inc. 2016
- Performance Evaluation Monoclonal Blood Typing Reagents Precision Testing Protocol awarded by Alba Bioscience Ltd 2015 - 2016
- Transfusion Medicine/Hemostasis Core Clinical Center awarded by National Institutes of Health 2007 - 2014
- Restoration and Function of S-nitrosothiol in Stored Blood awarded by National Institutes of Health 2009
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Bennett-Guerrero, Elliott, Jamie L. Romeiser, Lillian R. Talbot, Tahmeena Ahmed, Linda J. Mamone, Sunitha M. Singh, Janet C. Hearing, et al. “Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial.” Crit Care Med 49, no. 7 (July 1, 2021): 1015–25. https://doi.org/10.1097/CCM.0000000000005066.Full Text Link to Item
-
Jug, Rachel, Nicholas Bandarenko, and Jessica Poisson. “Management of Blood Product Market Withdrawals - A Single Institution's Process and Experience.” Ann Clin Lab Sci 50, no. 4 (July 2020): 536–40.Link to Item
-
Spinella, Philip C., Marisa Tucci, Dean A. Fergusson, Jacques Lacroix, Paul C. Hébert, Stéphane Leteurtre, Kenneth B. Schechtman, et al. “Effect of Fresh vs Standard-issue Red Blood Cell Transfusions on Multiple Organ Dysfunction Syndrome in Critically Ill Pediatric Patients: A Randomized Clinical Trial.” Jama 322, no. 22 (December 10, 2019): 2179–90. https://doi.org/10.1001/jama.2019.17478.Full Text Link to Item
-
Millward, Peter A., Alice Ma, Shauna N. Hay, Mark E. Brecher, and Nicholas Bandarenko. “Management of Gardner-Diamond syndrome with therapeutic plasma exchange.” J Clin Apher 32, no. 4 (August 2017): 273. https://doi.org/10.1002/jca.21484.Full Text Link to Item
-
Bennett-Guerrero, Elliott, Evelyn L. Lockhart, Nicholas Bandarenko, Mary L. Campbell, Michael J. Natoli, Veronika K. Jamnik, Timothy R. Carter, and Richard E. Moon. “A randomized controlled pilot study of VO2 max testing: a potential model for measuring relative in vivo efficacy of different red blood cell products.” Transfusion 57, no. 3 (March 2017): 630–36. https://doi.org/10.1111/trf.13918.Full Text Link to Item
-
Guinn, Nicole R., Nathan H. Waldron, Mary L. Cooter, Corinne L. Goldberg, Miklos D. Kertai, Karthik Raghunathan, Nicholas Bandarenko, Maureane Hoffman, and Elliott Bennett-Guerrero. “No association between donor age and recipient outcomes: transfusion of plasma in patients undergoing coronary artery bypass grafting surgery.” Transfusion 56, no. 7 (July 2016): 1723–29. https://doi.org/10.1111/trf.13616.Full Text Link to Item
-
Bennett-Guerrero, Elliott, Brett S. Kirby, Hongmei Zhu, Annadele E. Herman, Nicholas Bandarenko, and Timothy J. McMahon. “Randomized study of washing 40- to 42-day-stored red blood cells.” Transfusion 54, no. 10 (October 2014): 2544–52. https://doi.org/10.1111/trf.12660.Full Text Link to Item
-
Sarode, Ravi, Nick Bandarenko, Mark E. Brecher, Joseph E. Kiss, Marisa B. Marques, Zbigniew M. Szczepiorkowski, and Jeffrey L. Winters. “Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.” J Clin Apher 29, no. 3 (June 2014): 148–67. https://doi.org/10.1002/jca.21302.Full Text Link to Item
-
Alberts, Melissa, Nicholas Bandarenko, Jeffrey Gaca, Evelyn Lockhart, Carmelo Milano, Stanlin Alexander, Dean Linder, Frederick W. Lombard, and Ian J. Welsby. “Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion.” Transfusion 54, no. 5 (May 2014): 1348–57. https://doi.org/10.1111/trf.12463.Full Text Link to Item
-
Derienzo, Chris, P Brian Smith, David Tanaka, Nicholas Bandarenko, Mary Lee Campbell, Annadele Herman, Ronald N. Goldberg, and C Michael Cotten. “Feeding practices and other risk factors for developing transfusion-associated necrotizing enterocolitis.” Early Hum Dev 90, no. 5 (May 2014): 237–40. https://doi.org/10.1016/j.earlhumdev.2014.02.003.Full Text Link to Item
-
Lockhart, Evelyn L., Nicholas Bandarenko, Corinne L. Goldberg, Pamela S. Killian, and John L. Schmitz. “Posttransfusion thrombocytopenia: a cautionary tale of female group AB plasma.” Transfusion 53, no. 9 (September 2013): 2105–6. https://doi.org/10.1111/trf.12288.Full Text Link to Item
-
Bennett, Charles L., Sony Jacob, Brianne L. Dunn, Peter Georgantopoulos, X Long Zheng, Hau C. Kwaan, June M. McKoy, et al. “Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR).” Br J Haematol 161, no. 6 (June 2013): 896–98. https://doi.org/10.1111/bjh.12303.Full Text Link to Item
-
Jacob, Sony, Brianne L. Dunn, Zaina P. Qureshi, Nicholas Bandarenko, Hau C. Kwaan, Dilip K. Pandey, June M. McKoy, et al. “Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).” Semin Thromb Hemost 38, no. 8 (November 2012): 845–53. https://doi.org/10.1055/s-0032-1328894.Full Text Link to Item
-
Roberson, Russell S., Evelyn Lockhart, Nathan I. Shapiro, Nicholas Bandarenko, Timothy J. McMahon, Michael J. Massey, William D. White, and Elliott Bennett-Guerrero. “Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers.” Transfusion 52, no. 11 (November 2012): 2459–64. https://doi.org/10.1111/j.1537-2995.2012.03615.x.Full Text Link to Item
-
McRobb, C., R. Walczak, S. Lawson, A. Lodge, E. Lockhart, N. Bandarenko, and R. Ing. “Carboxyhemoglobinemia in a pediatric cardiopulmonary bypass patient derived from a contaminated unit of allogenic blood.” Perfusion 26, no. 4 (July 2011): 302–7. https://doi.org/10.1177/0267659111406993.Full Text Link to Item
-
Welsby, Ian J., Marla Troughton, Barbara Phillips-Bute, Rebecca Ramsey, Mary Lee Campbell, Nicholas Bandarenko, Joseph P. Mathew, Mark Stafford-Smith, and Mark Cardiothoracic Anesthesiology Research Endeavors. “The relationship of plasma transfusion from female and male donors with outcome after cardiac surgery.” J Thorac Cardiovasc Surg 140, no. 6 (December 2010): 1353–60. https://doi.org/10.1016/j.jtcvs.2009.12.035.Full Text Link to Item
-
Hursting, Marcie J., Poulomi J. Pai, Julianna E. McCracken, Fred Hwang, Shayela Suvarna, Yuliya Lokhnygina, Nicholas Bandarenko, and Gowthami M. Arepally. “Platelet factor 4/heparin antibodies in blood bank donors.” Am J Clin Pathol 134, no. 5 (November 2010): 774–80. https://doi.org/10.1309/AJCPG0MNR5NGKNFX.Full Text Link to Item
-
Welsby, Ian, Jennifer Crow, Nicholas Bandarenko, George Lappas, Barbara Phillips-Bute, and Mark Stafford-Smith. “A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery.” Transfusion 50, no. 11 (November 2010): 2337–43. https://doi.org/10.1111/j.1537-2995.2010.02711.x.Full Text Link to Item
-
Stafford-Smith, Mark, Evelyn Lockhart, Nicholas Bandarenko, and Ian Welsby. “Many, but not all, outcome studies support exclusion of female plasma from the blood supply.” Expert Rev Hematol 3, no. 5 (October 2010): 551–58. https://doi.org/10.1586/ehm.10.57.Full Text Link to Item
-
Szczepiorkowski, Zbigniew M., Jeffrey L. Winters, Nicholas Bandarenko, Haewon C. Kim, Michael L. Linenberger, Marisa B. Marques, Ravindra Sarode, et al. “Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.” J Clin Apher 25, no. 3 (2010): 83–177. https://doi.org/10.1002/jca.20240.Full Text Link to Item
-
Bennett-Guerrero, Elliott, Mark Stafford-Smith, Peter M. Waweru, Steven J. Bredehoeft, Mary Lee Campbell, N Rebecca Haley, Barbara Phillips-Bute, Mark F. Newman, and Nicholas Bandarenko. “A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients.” Transfusion 49, no. 7 (July 2009): 1375–83. https://doi.org/10.1111/j.1537-2995.2009.02152.x.Full Text Link to Item
-
Zakarija, Anaadriana, Hau C. Kwaan, Joel L. Moake, Nicholas Bandarenko, Dilip K. Pandey, June M. McKoy, Paul R. Yarnold, et al. “Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).” Kidney Int Suppl, no. 112 (February 2009): S20–24. https://doi.org/10.1038/ki.2008.613.Full Text Link to Item
-
Archin, Nancy M., Joseph J. Eron, Sarah Palmer, Anne Hartmann-Duff, Jeffery A. Martinson, Ann Wiegand, Nicholas Bandarenko, et al. “Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.” Aids 22, no. 10 (June 19, 2008): 1131–35. https://doi.org/10.1097/QAD.0b013e3282fd6df4.Full Text Link to Item
-
Millward, P. A., N. Bandarenko, and M. E. Brecher. “Therapeutic Apheresis: Basic Principles and Practical Aspects,” December 1, 2007, 727–37. https://doi.org/10.1016/B978-0-443-06981-9.50059-4.Full Text
-
Shaz, Beth H., Jeffrey L. Winters, Nicholas Bandarenko, and Zbigniew M. Szczepiorkowski. “How we approach an apheresis request for a Category III, Category IV, or noncategorized indication.” Transfusion 47, no. 11 (November 2007): 1963–71. https://doi.org/10.1111/j.1537-2995.2007.01511.x.Full Text Link to Item
-
Bennett, Charles L., Benjamin Kim, Anaadriana Zakarija, Nicholas Bandarenko, Dilip K. Pandey, Charlie G. Buffie, June M. McKoy, et al. “Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.” J Am Coll Cardiol 50, no. 12 (September 18, 2007): 1138–43. https://doi.org/10.1016/j.jacc.2007.04.093.Full Text Link to Item
-
Shaz, Beth H., Michael L. Linenberger, Nicholas Bandarenko, Jeffrey L. Winters, Haewon C. Kim, Marisa B. Marques, Ravindra Sarode, et al. “Category IV indications for therapeutic apheresis: ASFA fourth special issue.” J Clin Apher 22, no. 3 (June 2007): 176–80. https://doi.org/10.1002/jca.20131.Full Text Link to Item
-
Szczepiorkowski, Zbigniew M., Beth H. Shaz, Nicholas Bandarenko, and Jeffrey L. Winters. “The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.” J Clin Apher 22, no. 3 (June 2007): 96–105. https://doi.org/10.1002/jca.20134.Full Text Link to Item
-
Szczepiorkowski, Zbigniew M., Nicholas Bandarenko, Haewon C. Kim, Michael L. Linenberger, Marisa B. Marques, Ravindra Sarode, Joseph Schwartz, et al. “Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.” J Clin Apher 22, no. 3 (June 2007): 106–75. https://doi.org/10.1002/jca.20129.Full Text Link to Item
-
Bandarenko, Nicholas, Jose Cancelas, Edward L. Snyder, Shauna N. Hay, Neeta Rugg, Tammy Corda, Amy D. Joines, et al. “Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system.” Transfusion 47, no. 4 (April 2007): 680–86. https://doi.org/10.1111/j.1537-2995.2007.01171.x.Full Text Link to Item
-
Afenyi-Annan, Araba, Mark E. Brecher, and Nicholas Bandarenko. “Update on multi-center clinical trials in the United States.” Transfus Apher Sci 36, no. 1 (February 2007): 5–12. https://doi.org/10.1016/j.transci.2006.10.007.Full Text Link to Item
-
Coghill, James, Terrance Comeau, Thomas Shea, Linda Braddy, Nicholas Bandarenko, Araba Afenyi-Annan, and Donald Harvey. “Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG).” Biol Blood Marrow Transplant 12, no. 7 (July 2006): 786–88. https://doi.org/10.1016/j.bbmt.2006.03.003.Full Text Link to Item
-
Hay, Shauna N., Jennifer A. Egan, Peter A. Millward, Nicholas Bandarenko, and Mark E. Brecher. “Patterns of platelet response in idiopathic TTP/HUS: frequency of declining platelet counts with plasma exchange and the recognition and significance of a pseudo refractory state.” Ther Apher Dial 10, no. 3 (June 2006): 237–41. https://doi.org/10.1111/j.1744-9987.2006.00368.x.Full Text Link to Item
-
Afenyi-Annan, A., and N. Bandarenko. “Transfusion practices for patients with sickle cell disease at a major academic medical center.” Immunohematology 22, no. 3 (2006): 103–7.Link to Item
-
Willis, Monte S., and Nicholas Bandarenko. “Relapse of thrombotic thrombocytopenic purpura: is it a continuum of disease?” Semin Thromb Hemost 31, no. 6 (December 2005): 700–708. https://doi.org/10.1055/s-2005-925476.Full Text Link to Item
-
Millward, P. M., N. Bandarenko, P. P. Chang, K. F. Stagg, A. Afenyi-Annan, S. N. Hay, and M. E. Brecher. “Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.” Transfusion 45, no. 9 (September 2005): 1481–86. https://doi.org/10.1111/j.1537-2995.2005.00560.x.Full Text Link to Item
-
Bandarenko, Nicholas, Shauna N. Hay, Jerry Holmberg, Pam Whitley, Harry L. Taylor, Gary Moroff, Leslie Rose, et al. “Extended storage of AS-1 and AS-3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS-3 using an automated closed system.” Transfusion 44, no. 11 (November 2004): 1656–62. https://doi.org/10.1111/j.1537-2995.2004.04101.x.Full Text Link to Item
-
Zakarija, Anaadriana, Nicholas Bandarenko, Dilip K. Pandey, Amy Auerbach, Dennis W. Raisch, Benjamin Kim, Hau C. Kwaan, et al. “Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration.” Stroke 35, no. 2 (February 2004): 533–37. https://doi.org/10.1161/01.STR.0000109253.66918.5E.Full Text Link to Item
-
Egan, J. A., N. Bandarenko, S. N. Hay, L. Paradowski, R. Goldberg, V. Nickeleit, and M. E. Brecher. “Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura.” J Clin Apher 19, no. 3 (2004): 125–29. https://doi.org/10.1002/jca.20016.Full Text Link to Item
-
Bandarenko, Nicholas, and Helen Jones. “A large university medical center delivery system for therapeutic apheresis services.” Transfus Apher Sci 28, no. 2 (April 2003): 165–71. https://doi.org/10.1016/S1473-0502(03)00006-5.Full Text Link to Item
-
Bandarenko, N., M. Rose, R. J. Kowalsky, R. K. Baston, M. E. Brecher, M. D. Elfath, P. Whitley, M. Heminway, and S. Holme. “In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter.” Transfusion 41, no. 11 (November 2001): 1373–77. https://doi.org/10.1046/j.1537-2995.2001.41111373.x.Full Text Link to Item
-
Means, N. D., N. Bandarenko, K. J. Moise, and M. E. Brecher. “Likelihood of D heterozygosity in Mestizo Mexicans and Mexican Americans.” Immunohematology 17, no. 1 (2001): 22–23.Link to Item
-
Reutter, J. C., K. F. Sanders, M. E. Brecher, H. G. Jones, and N. Bandarenko. “Incidence of allergic reactions with fresh frozen plasma or cryo-supernatant plasma in the treatment of thrombotic thrombocytopenic purpura.” J Clin Apher 16, no. 3 (2001): 134–38. https://doi.org/10.1002/jca.1025.Full Text Link to Item
-
Sood, N., N. Bandarenko, and L. J. Paradowski. “Acute respiratory failure secondary to lymphangitic carcinomatosis (vol 18, pg 229, 2000).” Journal of Clinical Oncology 18, no. 4 (February 1, 2000): 944–944.Link to Item
-
Sood, N., N. Bandarenko, and L. J. Paradowski. “Case 2: acute respiratory failure secondary to lymphangitic carcinomatosis.” J Clin Oncol 18, no. 1 (January 2000): 229–32. https://doi.org/10.1200/JCO.2000.18.1.229.Full Text Link to Item
-
Brailey, L. L., M. E. Brecher, and N. Bandarenko. “Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology, and management.” Ther Apher 3, no. 1 (February 1999): 20–24. https://doi.org/10.1046/j.1526-0968.1999.00143.x.Full Text Link to Item
-
Huston, B. M., M. E. Brecher, and N. Bandarenko. “Lack of efficacy for conventional gamma irradiation of platelet concentrates to abrogate bacterial growth.” Am J Clin Pathol 109, no. 6 (June 1998): 743–47. https://doi.org/10.1093/ajcp/109.6.743.Full Text Link to Item
-
Creager, A. J., M. E. Brecher, and N. Bandarenko. “Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection.” Transfusion 38, no. 5 (May 1998): 419–23. https://doi.org/10.1046/j.1537-2995.1998.38598297208.x.Full Text Link to Item
-
Bandarenko, N., and M. E. Brecher. “United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange.” J Clin Apher 13, no. 3 (1998): 133–41. https://doi.org/10.1002/(sici)1098-1101(1998)13:3<133::aid-jca7>3.0.co;2-z.Full Text Link to Item
-
Cohen, J. A., M. E. Brecher, and N. Bandarenko. “Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura.” J Clin Apher 13, no. 1 (1998): 16–19. https://doi.org/10.1002/(sici)1098-1101(1998)13:1<16::aid-jca3>3.0.co;2-c.Full Text Link to Item
-
Bandarenko, N., L. C. Sims, and M. E. Brecher. “Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yields.” Transfusion 37, no. 11–12 (1997): 1218. https://doi.org/10.1046/j.1537-2995.1997.37111298088057.x.Full Text Link to Item
-
Brecher, M. E., H. G. Owen, and N. Bandarenko. “Alternatives to albumin: starch replacement for plasma exchange.” J Clin Apher 12, no. 3 (1997): 146–53. https://doi.org/10.1002/(sici)1098-1101(1997)12:3<146::aid-jca8>3.0.co;2-a.Full Text Link to Item
-
Bandarenko, N., H. G. Owen, D. C. Mair, and M. E. Brecher. “Apheresis. New opportunities.” Clin Lab Med 16, no. 4 (December 1996): 907–29.Link to Item
-
Hettasch, J. M., N. Bandarenko, J. L. Burchette, T. S. Lai, J. R. Marks, Z. A. Haroon, K. Peters, M. W. Dewhirst, J. D. Iglehart, and C. S. Greenberg. “Tissue transglutaminase expression in human breast cancer.” Lab Invest 75, no. 5 (November 1996): 637–45.Link to Item
-
Bandarenko, N., M. E. Brecher, H. Owen, J. Wiley, T. Shea, and J. Serody. “Thrombocytopenia in allogeneic peripheral blood stem cell collections.” Transfusion 36, no. 7 (July 1996): 668–69. https://doi.org/10.1046/j.1537-2995.1996.36796323066.x.Full Text Link to Item
-
Marks, J. R., P. A. Humphrey, K. Wu, D. Berry, N. Bandarenko, B. J. Kerns, and J. D. Iglehart. “Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.” Ann Surg 219, no. 4 (April 1994): 332–41. https://doi.org/10.1097/00000658-199404000-00002.Full Text Link to Item
-
-
Book Sections
-
Millward, P. A., N. Bandarenko, and M. E. Brecher. “Therapeutic Apheresis: Basic Principles and Practical Aspects.” In Blood Banking and Transfusion Medicine: Basic Principles and Practice: Second Edition, 727–37, 2006. https://doi.org/10.1016/B978-0-443-06981-9.50059-4.Full Text
-
-
Conference Papers
-
Bandarenko, Nicholas, Audrey Labrie, Elisabeth Maurer, and Jessica Poisson. “Observed Difference in Platelet Activation Status Between the Third Container Compared to Containers 1 and 2 of Triple Platelet Donations.” In Transfusion, 59:38A-38A. WILEY, 2019.Link to Item
-
Bandarenko, Nicholas, Audrey Labrie, Elisabeth Maurer-Spurej, and Jessica Poisson. “Effects of Transport by Pneumatic Tube System on Platelet Activation Status as Measured by Dynamic Light Scattering: A Pilot Study.” In Transfusion, 59:175A-175A. WILEY, 2019.Link to Item
-
Robinson, Todd, Nicholas Bandarenko, Ethan Davis, and Jessica Poisson. “Sample Loading Strategies Can Negatively Affect Turnaround Time on an Automated Immunohematology Analyzer.” In Transfusion, 59:149A-149A. WILEY, 2019.Link to Item
-
Bandarenko, Nicholas, Roberta Arney, Nancy Diaddezzio, Mary Campbell, and Jessica Poisson. “The Successful Role of a Suggestion Box as Part of the Transfusion Service Quality System: A 10 Year Retrospective.” In Transfusion, 58:156A-157A. WILEY, 2018.Link to Item
-
Marks, Martha, Robert T. Robinson, Jaylen Rivera, Leah M. Golden, Jessica Poisson, Melissa J. A. Laufer, Bob Pembroke, and Nicholas Bandarenko. “Comparing Gel to Solid Phase Methodologies in a Large Hospital Transfusion Service: Concordance Data of High-Throughput Automated Immunohematology Analyzers.” In Transfusion, 58:140A-140A. WILEY, 2018.Link to Item
-
Simmons, Heather, Martha R. Combs, Nicholas Bandarenko, and Jessica Poisson. “Evaluation of a Workflow to Manage Inconclusive Solid Phase Reactivity.” In Transfusion, 58:174A-174A. WILEY, 2018.Link to Item
-
Combs, Martha Rae, Heather Simmons, Christine Lomas-Francis, Gayane Shakarian, Sunitha Vege, Lauren Hutelmyer, Sandra Nance, Jessica Poisson, Nicholas Bandarenko, and Connie M. Westhoff. “Transient Kell and Scianna Antigen Suppression in a Ul(a plus ) Homozygote.” In Transfusion, 57:160A-160A. WILEY, 2017.Link to Item
-
Jug, Rachel, Gustaaf de Ridder, Kimberly Ingersoll, Susan Violet, Nicholas Bandarenko, and Jessica Poisson. “Blood Product Wastage in Massive Transfusion Protocols.” In Transfusion, 57:66A-67A. WILEY, 2017.Link to Item
-
Ridder, Gustaaf de, Rachel Jug, Kimberly Ingersoll, Nicholas Bandarenko, Nicole Guinn, and Jessica Poisson. “Objective Performance of Massive Transfusion Protocols at a Single Institution.” In Transfusion, 57:256A-256A. WILEY, 2017.Link to Item
-
Sen, Siddhartha, Martha Rae Combs, Jessica Poisson, and Nicholas Bandarenko. “RBC Transfusion in Calcineurin Inhibitor Related Hemolytic Anemia.” In Transfusion, 57:126A-127A. WILEY, 2017.Link to Item
-
Bennett, Charles, Masanori Matsumoto, Peter Georgantopoulos, Sony Jacob, Brianne L. Dunn, Zaina Parvez Qureshi, Nicholas Bandarenko, et al. “Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.” In Blood, 120:2203–2203. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.2203.2203.Full Text
-
Lockhart, E., J. C. Stover, B. W. Broomer, W. D. White, P. Papavassiliou, N. Bandarenko, and S. E. Hill. “Acceptance of Cryoprecipitate and Cryosupernatant By Adult Jehovah's Witness Patients After Informed Consent.” In Transfusion, 52:113A-113A. WILEY-BLACKWELL, 2012.Link to Item
-
Alberts, M., P. Roman, I. Welsby, J. Gaca, N. Bandarenko, E. Lockhart, S. Alexander, and I. Shearer. “Using Intra-Operative Apheresis During Cardiac Surgery to Reduce Allogeneic Transfusion Rates.” In Transfusion, 51:83A-83A. WILEY-BLACKWELL, 2011.Link to Item
-
Bandarenko, N., R. Walczak, E. Lockhart, M. Campbell-Lee, R. Ing, A. J. Lodge, J. Jaggers, S. Lawson, and C. McRobb. “Transfusion-Acquired Carboxyhemoglobinemia During Pediatric Cardiac Surgery.” In Transfusion, 50:22A-23A. WILEY-BLACKWELL PUBLISHING, INC, 2010.Link to Item
-
Di Addezzio, N. A., K. King, M. Campbell-Lee, E. Lockhart, and N. Bandarenko. “Process Improvement with Full Staff Participation Using Six Sigma: Analysis of Dispense Errors.” In Transfusion, 50:268A-268A. WILEY-BLACKWELL PUBLISHING, INC, 2010.Link to Item
-
Lockhart, E., M. Campbell, L. Laureano, M. D. Robinson, L. Vandevander, J. Bumgarner, D. S. Allen, and N. Bandarenko. “Hemoconcentration of Red Blood Cell Units for Intrauterine Transfusion Using the Cobe 2991 Cell Processor.” In Transfusion, 50:74A-74A. WILEY-BLACKWELL PUBLISHING, INC, 2010.Link to Item
-
Zakarija, Anaadriana, Thanh Ha Luu, Hau C. Kwaan, June McKoy, Ivy Weiss, Paul Yarnold, Nicholas Bandarenko, and Charles L. Bennett. “Thienopyridine-Associated Thrombotic Thrombocytopenia Purpura: Updated Antibody Results From the SERF-TTP Study.” In Blood, 114:367–68. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Campbell, M., E. C. Randle, M. Covert, R. Kasbekar, E. L. Lockhart, S. Beisser, and N. Bandarenko. “Cooler Hemovigilance: Blood Utilization Analysis of Temporary Storage Devices for Blood Products.” In Transfusion, 49:268A-268A. WILEY-BLACKWELL PUBLISHING, INC, 2009.Link to Item
-
Zakarija, Anaadriana, Paul Yarnold, Hau Kwaan, Thanh Ha Luu, Dilip Pandey, John Cursio, Nicholas Bandarenko, Elizabeth A. Richey, Ivy Weiss, and Charles L. Bennett. “Idiopathic TTP: predictors of relapse and mortality from the serf(surveillance, epidemiology and risk factors)-TTP group.” In Haemophilia, 15:627–627. WILEY-BLACKWELL PUBLISHING, INC, 2009.Link to Item
-
Bennett, Charles L., Anaadriana Zakarija, Hau C. Kwaan, Dilip Pandey, Paul Yarnold, John F. Cursio, Robert Soltysik, et al. “Distinct Mechanisms of Idiopathic and Thienopyridine-Assocaited Thrombotic Thrombocytopenia Purpura: Final Results from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.” In Blood, 112:800–800. AMER SOC HEMATOLOGY, 2008.Link to Item
-
Campbell, M. L., I. Welsby, B. Phillips-Bute, R. Ramsey, N. Bandarenko, T. Boyd, and M. Stafford-Smith. “Apheresis platelet donor gender and outcome after cardiac surgery.” In Transfusion, 48:28A-28A. BLACKWELL PUBLISHING, 2008.Link to Item
-
Welsby, I., M. Troughton, N. Bandarenko, Mark Stafford-Smith, Barbara Phillips-Bute, and R. Ramsay. “The association of plasma donor gender with short and long-term outcome after cardiac surgery.” In Transfusion, 48:206A-206A. BLACKWELL PUBLISHING, 2008.Link to Item
-
Zakarija, A., P. Yarnold, H. Kwaan, D. Pandey, N. Bandarenko, T. H. Luu, J. Cursio, et al. “Idiopathic TTP: Predictors of relapse and mortality from the SERF (surveillance, epidemiology and risk Factors)-TTP group.” In Transfusion, 48:256A-256A. WILEY, 2008.Link to Item
-
Bennett, Charies L., Thanh Ha Luu, Anaadriana Zakarija, Hau C. Kwaan, Nicholas Bandarenko, Dilip K. Pandey, John F. Cursio, et al. “Clinical and outcomes findings for thrombotic thrombocytopenic purpura among 467 persons with severely versus not severely deficient ADAMTS13 levels.” In Blood, 110:622A-622A. AMER SOC HEMATOLOGY, 2007.Link to Item
-
Archin, N. M., J. Eron, S. Palmer, L. Ngo, A Hartmann Duff, N. Bandarenko, J. Schmitz, et al. “Standard ART and valproic acid have limited impact on persistent HIV infection of resting CD4(+) T-cells.” In Antiviral Therapy, 12:S107–S107. INT MEDICAL PRESS LTD, 2007.Link to Item
-
Archin, N. M., J. Eron, S. Palmer, L. Ngo, Hartmann Duff, N. Bandarenko, J. Schmitz, et al. “Standard ART and valproic acid have limited impact on persistent HIV infection of resting CD4(+) T-cells.” In Antiviral Therapy, 12:S107–S107, 2007.Link to Item
-
Zakarija, Anaadriana, H. C. Kwaan, Nicholas Bandarenko, Dilip Pandey, Amul Tevar, John Cursio, Charles Buffie, et al. “Preliminary results from the surveillance, epidemiology & risk factors for TTP (SERF-TTP) group: A prospective case-control study of idiopathic TTP.” In Blood, 108:316A-317A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
Kim, Benjamin, Charles Davidson, Hau C. Kwaan, Anaadriana Zakarija, Nicholas Bandarenko, Dilip K. Pandey, Ravindra Sarode, et al. “Characteristics of two thrombotic thrombocytopenic purpura (TTP) syndromes associated with ticlopidine and clopidogrel: Results from the surveillance, epidemiology, and risk factors for thrombotic thrombocytopenic purpura (SERF-TTP) research group.” In Circulation, 114:72–73. LIPPINCOTT WILLIAMS & WILKINS, 2006.Link to Item
-
Bandarenko, N., A. Zakarija, B. Kim, H. C. Kwaan, J. M. Mckoy, D. K. Pandey, S. N. Hay, et al. “Two mechanistic pathways of ticlopidine- and Clopidogrel-Associated TTP: Results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) research.” In Transfusion, 46:29A-29A. WILEY, 2006.Link to Item
-
Bandarenko, N., A. Zakarija, D. K. Pandey, J. F. Cursio, A. D. Tevar, J. L. Winters, R. Sarode, S. N. Hay, and C. L. Bennett. “A prospective case-control study of incident TTP: Preliminary results of risk factors for development of the TTP/HUS syndrome.” In Transfusion, 46:28A-28A. WILEY, 2006.Link to Item
-
Cancelas, J. A., N. Bandarenko, E. Snyder, N. Rugg, S. N. Hay, L. Baril, T. Corda, et al. “Cryopreservation of AS-5-collected red blood cells in PVC or EVA bags by the closed ACP (R) 215 system allows extended storage for 14 days post-thawing.” In Transfusion, 46:17A-17A. BLACKWELL PUBLISHING, 2006.Link to Item
-
Zakarija, A., H. C. Kwaan, N. Bandarenko, I. Weiss, D. K. Pandey, J. F. Cursio, A. D. Tevar, et al. “ADAMTS13 activity and autoantibodies in a prospective cohort of idiopathic TTP: Preliminary results from the surveillance, epidemiology, and risk factors for TTP (SERF-TTP) group.” In Transfusion, 46:43A-43A. WILEY, 2006.Link to Item
-
Kwaan, H. C., J. M. McKoy, K. R. McCaffrey, P. R. Yarold, B. Kim, A. Zakarija, N. Bandarenko, et al. “ADAMTS13 levels support hypothesis of distinct mechanistic pathways for early versus late-onset of thienopyridine-associated thrombotic thrombocytopenic purpura (TTP).” In Blood, 106:22A-22A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Zakarija, A., K. R. McCaffrey, N. Bandarenko, D. Pandey, J. Cursio, A. Tevar, H. Kwaan, P. R. Yarnold, M. Burton, and C. L. Bennett. “Incident TTP: Plasmapheresis therapy-related complications are common.” In Blood, 106:365A-365A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Braddy, L., J. Coghill, A. Afenyi-Annan, D. Harvey, T. Shea, T. Comeau, and N. Bandarenko. “Acute hemolysis associated with passively acquired anti-A from intravenous gamma globulin (IVIG).” In Transfusion, 45:134A-134A. BLACKWELL PUBLISHING, 2005.Link to Item
-
Snyder, E. L., N. Bandarenko, M. Rose, L. Baril, S. N. Hay, T. Corda, D. Dincecco, L. Rose, and M. Popovsky. “Evaluation of CPDA1 red cells glycerolized, frozen, stored at-65 degrees C or colder and deglycerolized by using an automated closed system.” In Transfusion, 45:68A-68A. BLACKWELL PUBLISHING, 2005.Link to Item
-
Zakarija, A., N. Bandarenko, D. K. Pandey, H. Kwaan, A. Tevar, J. Cursio, K. R. McCaffrey, and C. L. Bennett. “A prospective case-control study of incident TTP: Preliminary results of treatment patterns and adverse events.” In Transfusion, 45:39A-39A. WILEY, 2005.Link to Item
-
Kim, Benjamin, Kenneth R. Carson, Kathryn McCaffrey, Denise Finley, Anaadriana Zakarija, Nicholas Bandarenko, Dilip K. Pandey, et al. “Are There Two Distinct Mechanistic Pathways That Explain the Varying Clinical Presentations, Laboratory Findings, and Outcomes of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)?.” In Blood, 104:860–860. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.860.860.Full Text
-
Zakarija, Anaadriana, Nicholas Bandarenko, Dilip K. Pandey, Hau Kwaan, Kathryn McCaffrey, Denise Finley, Ken Carson, Paul Yarnold, and Charles L. Bennett. “Preliminary Findings from the Prospective Multicenter Surveillance, Epidemiology and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) Study.” In Blood, 104:855–855. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.855.855.Full Text
-
Bandarenko, N., J. L. Winters, S. Hay, D. Pandey, A. Zakarija, D. Finley, L. Palfalvi, et al. “Centralized coordination for conducting multi-site studies for TTP in the era of HIPAA: The importance of centralized coordination of IRB activities.” In Transfusion, 44:39A-40A. BLACKWELL PUBLISHING INC, 2004.Link to Item
-
Bandarenko, N., K. F. Stagg, S. N. Hay, and M. E. Brecher. “Cardiogenic shock complicates successful treatment of refractory TTP with rituximab.” In Transfusion, 44:44A-44A. BLACKWELL PUBLISHING INC, 2004.Link to Item
-
Bandarenko, N., M. Rose, S. N. Hay, L. Rose, and M. Popovsky. “Efficient washing and satisfactory 24-hour post-wash storage of AS-1, AS-3, AS-5 and CPDA-1 red cell units using an automated closed system.” In Transfusion, 44:73A-74A. BLACKWELL PUBLISHING INC, 2004.Link to Item
-
Egan, J. A., N. Bandarenko, S. N. Hay, L. J. Paradowski, R. M. Goldberg, V. Nickeleit, and M. E. Brecher. “Differentiating severe hypertension with thrombotic microangiopathic anemia and thrombocytopenia from thrombotic thrombocytopenia purpura.” In Transfusion, 44:134A-134A. BLACKWELL PUBLISHING INC, 2004.Link to Item
-
Comeau, T., J. Serody, D. A. Gabriel, J. Wiley, S. Kirby, R. Irons, D. Hill, et al. “Combined infusion of peripheral blood stem cells (PBSC) plus bone marrow (BM) in poorly mobilizing patients undergoing high-dose therapy (HDT) and autologous stem cell transplant (ASCT).” In Blood, 102:988A-989A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Kim, B., A. Auerbach, A. Zakarija, D. K. Pandey, N. Bandarenko, D. Raisch, H. Kwaan, P. R. Yarnold, and C. L. Bennett. “Clopidogrel-associated TTP: Comparison of quality and timeliness of case reports obtained from the FDA, the pharmaceutical supplier, and from active pharmacovigilance.” In Blood, 102:496A-497A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Zakarija, A., N. Bandarenko, D. K. Pandey, D. Raisch, H. C. Kwaan, J. McKoy, P. Yarnold, and C. L. Bennett. “Clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Clinical characteristics and predictors of survival.” In Blood, 102:539A-539A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Taylor, H., N. Bandarenko, J. Holmberg, P. Whitley, S. Sawyer, A. Johnson, D. McNeil, et al. “Evaluation of the ACP((r)) system for glycerolization of whole blood-derived red blood cells stored in AS-1 or AS-3, deglycerolized and suspended with AS-3 in a closed system.” In Transfusion, 43:41A-42A. AMER ASSOC BLOOD BANKS, 2003.Link to Item
-
Bandarenko, N., M. Rose, S. N. Hay, J. Holmberg, L. Rose, and M. Popovsky. “Efficient automated washing of AS-1, AS-3, AS-5 and CPDA-1 stored red cell units using a closed system.” In Transfusion, 42:53S-53S. AMER ASSOC BLOOD BANKS, 2002.Link to Item
-
Bandarenko, N., R. K. Baston, M. E. Brecher, D. Elfath, P. H. Whitley, R. Rose, M. Heminway, and S. Holme. “Iin-line leukoreduction of warm or cold stored apheresis collected two RBC units using a single disposable set.” In Transfusion, 40:18S-18S. AMER ASSOC BLOOD BANKS, 2000.Link to Item
-
Bandarenko, N., N. D. Means, S. B. Schoultz, C. A. Evoy, T. Shea, and H. G. Jones. “Failure to reach a circulating CD34+threshold for PBSC harvest: Implications for transplantation.” In Transfusion, 39:102S-102S. AMER ASSOC BLOOD BANKS, 1999.Link to Item
-
Wong, E. C. C., M. E. Brecher, B. Huston, A. Kaplan, K. Lehman, K. Mitchell, and N. Bandarenko. “Efficacy of high dose gamma irradiation on bacterial growth in apheresis platelets.” In Transfusion, 38:75S-75S. AMER ASSOC BLOOD BANKS, 1998.Link to Item
-
Wong, E. C. C., M. E. Brecher, P. Parker, C. Sohier, B. Korycha, and N. Bandarenko. “Effect of high dose gamma irradiation on platelet biochemistry and aggregation.” In Transfusion, 38:75S-75S. AMER ASSOC BLOOD BANKS, 1998.Link to Item
-
Wong, E. C. C., M. E. Brecher, V. Madden, and N. Bandarenko. “Ultrastructural changes of platelets irradiated at 30,000 cGy.” In Transfusion, 38:76S-76S. AMER ASSOC BLOOD BANKS, 1998.Link to Item
-
Bandarenko, N., and M. E. Brecher. “Stratified standard surgical blood order schedule for autologous blood donation.” In Transfusion, 37:S149–S149. AMER ASSOC BLOOD BANKS, 1997.Link to Item
-
Bandarenko, N., and M. E. Brecher. “US TTP apheresis study group (US TTP ASG): Response time with daily plasmapheresis in TTP.” In Transfusion, 37:S269–S269. AMER ASSOC BLOOD BANKS, 1997.Link to Item
-
Creager, A. J., M. E. Brecher, and N. Bandarenko. “Thrombotic thrombocytopenic purpura refractory to therapeutic plasma exchange in two patients with occult infection.” In Transfusion, 37:S178–S178. AMER ASSOC BLOOD BANKS, 1997.Link to Item
-
Huston, B. M., N. Bandarenko, and M. E. Brecher. “Lack of efficacy for conventional gamma irradiation of platelet concentrates to abrogate bacterial growth.” In Transfusion, 37:S198–S198. AMER ASSOC BLOOD BANKS, 1997.Link to Item
-
BANDARENKO, N., C. C. SANTOS, G. R. DELONG, and D. C. ANTHONY. “GIANT NEUROFILAMENTOUS SPHEROIDS IN THE ANTERIOR HORN OF AN INFANT WITH ATYPICAL MOTOR-NEURON DISEASE (SPINAL MUSCULAR-ATROPHY).” In Journal of Neuropathology and Experimental Neurology, 50:307–307. AMER ASSN NEUROPATHOLOGISTS INC, 1991.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.